The ACTC1/ACTA1/ACTG2 Monoclonal Antibody is a highly specific immunoglobulin targeting three actin isoforms: ACTC1 (actin alpha cardiac muscle 1), ACTA1 (actin alpha skeletal muscle), and ACTG2 (actin gamma-2 smooth muscle). These isoforms are critical for cellular motility, muscle contraction, and structural integrity . Monoclonal antibodies (mAbs) like this are derived from a single cell line, ensuring uniform specificity and reproducibility . This antibody is widely used in research to study actin-related pathologies, including cardiomyopathies, myopathies, and cancer metastasis .
Function: Essential for cardiac muscle contraction and sarcomere organization .
Clinical Relevance: Mutations linked to dilated cardiomyopathy (DCM) and hypertrophic cardiomyopathy (HCM) .
Function: Dominant isoform in adult skeletal muscle; mediates force generation during contraction .
Clinical Relevance: Mutations associated with nemaline myopathy and congenital myopathies .
Function: Critical for smooth muscle contraction in vascular and gastrointestinal tissues .
Clinical Relevance: Dysregulation implicated in glioblastoma migration and visceral myopathies .
The ACTC1/ACTA1/ACTG2 Monoclonal Antibody (e.g., clone ABT-ACTN) exhibits the following properties :
Cardiac Research: Used to detect ACTC1 expression in myocardial tissue, aiding in the diagnosis of cardiomyopathies .
Cancer Biology: ACTG2 overexpression in glioblastoma correlates with tumor invasiveness; this antibody helps identify metastatic potential .
Muscle Disorders: Enables differentiation between ACTA1-related myopathies and other muscular dystrophies .
Contractility Studies: Acta2 (smooth muscle actin) knockout mice showed defective lactation due to impaired myoepithelial cell contraction, highlighting actin isoform specificity .
Cytoskeletal Dynamics: In glioblastoma cells, ACTA2 knockdown reduced migration and proliferation, validated using this antibody .